HAE Stock Price, Chart, Stats & News

Haemonetics Corporation
Save
3.31B
Market cap
14.66x
Current P/E
13.95x
Forward P/E
HAE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 58.49% |
Operating margin | 19.21% |
Pretax margin | 17.23% |
Net margin | 13.31% |
Effective tax rate | 22.77% |
ROA | 7.04% |
ROE | 20.26% |
D/E | 1.34x |
Interest coverage ratio | 12.66x |
HAE valuation
P/E | 14.66x |
P/S | 1.92x |
P/B | 2.77x |
P/CF | 7.46x |
P/FCF | 8.21x |
P/OCF | 7.46x |
PEG | 2.36x |
EV multiple | 4.44x |
About
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains.
Similar securities
Based on sector and market capitalization
Report issue











